The 280E Tax Burden: Why Cannabis Businesses Pay More Than You Think
Section 280E forces cannabis businesses to pay effective tax rates up to 70%. Here's how this IRS code shapes the industry and what may change.
Professor High
Your friendly cannabis educator, bringing science-backed knowledge to the community.
The News
While most American businesses deduct ordinary expenses like rent, payroll, and marketing from their taxable income, cannabis companies cannot. The reason is a four-decade-old provision in the Internal Revenue Code — Section 280E — that was originally written to prevent drug traffickers from claiming tax deductions. Today, it applies to every state-legal cannabis business in the country, creating effective tax rates that can climb as high as 70% or more, compared to the 21% federal corporate rate most industries enjoy.
Despite cannabis generating over $30 billion in annual legal sales across 40+ state markets, the federal government still classifies it as a Schedule I controlled substance. That classification triggers 280E, which states that no deduction or credit shall be allowed for any amount paid in carrying on a trade or business that consists of trafficking in controlled substances. The result: legal cannabis operators are taxed on their gross profit rather than their net income, a financial reality that has driven countless businesses toward insolvency and reshaped the entire industry’s economics.
“We pay taxes as if we’re drug dealers, but we’re regulated like pharmaceutical companies.” — A sentiment echoed across the legal cannabis industry.
Context & Background
How We Got Here
Section 280E was enacted in 1982 after a drug dealer named Jeffrey Edmondson successfully claimed tax deductions for his illegal operation — including a scale, baggies, and even a phone line used for sales. The court ruled in his favor because the existing tax code allowed it. Congress responded swiftly by passing 280E to ensure that no business trafficking in Schedule I or Schedule II controlled substances could deduct business expenses.
At the time, no one envisioned a world where cannabis would be legally sold in retail storefronts, tested in state-certified labs, and taxed at the state level. Yet here we are: 24 states plus Washington, D.C. have legalized adult-use cannabis, and 38 states have medical programs. The federal-state disconnect has created what many industry analysts call the most punitive tax environment for any legal business in modern American history.
The Math Behind the Pain
For a typical business, taxable income is calculated as revenue minus all ordinary and necessary expenses — salaries, rent, utilities, marketing, insurance, and so on. For cannabis businesses, only Cost of Goods Sold (COGS) can be deducted. Everything else — from budtender wages to security systems to compliance software — is non-deductible.
Here’s a simplified comparison:
| Traditional Business | Cannabis Business | |
|---|---|---|
| Revenue | $1,000,000 | $1,000,000 |
| COGS | $400,000 | $400,000 |
| Operating Expenses | $350,000 | $350,000 |
| Taxable Income | $250,000 | $600,000 |
| Federal Tax (21%) | $52,500 | $126,000 |
| Effective Tax Rate | ~5.3% of revenue | ~12.6% of revenue |
And that’s before state cannabis excise taxes, local taxes, and state income taxes stack on top. Some operators report total effective tax rates exceeding 70% of their actual net income.
What This Means
For Consumers
You might not see 280E listed on your dispensary receipt, but you’re feeling its effects every time you make a purchase. When businesses can’t deduct operating costs, those costs get baked into the retail price of cannabis products. Industry analysts estimate that 280E contributes to prices being 10-20% higher than they would be in a normalized tax environment.
This pricing pressure also makes it harder for the legal market to compete with the illicit market, which obviously pays no federal taxes at all. In states like California and New York, where illicit sales still dominate, the tax burden is frequently cited as a primary reason consumers haven’t transitioned to licensed retailers. If you’ve ever wondered why legal cannabis costs so much more than what’s available on the unregulated market, 280E is a significant piece of that puzzle.
For the Industry
The impact on cannabis businesses has been devastating and wide-ranging:
- Cash flow crises: Companies owe taxes on income they didn’t actually earn as profit, draining working capital
- Business closures: Hundreds of licensed operators have shut down in part due to unsustainable tax obligations
- Reduced investment: Investors are wary of an industry where profitability is structurally undermined by federal tax policy
- Accounting complexity: Businesses spend heavily on specialized cannabis tax accountants and attorneys to maximize their COGS deductions — an ironic additional cost they also can’t deduct
- Competitive distortion: Multi-state operators with vertically integrated supply chains can capture more COGS deductions than standalone retailers, tilting the playing field
The IRS has aggressively audited cannabis businesses, and 280E disputes have generated a substantial body of tax court cases. Companies that have attempted creative interpretations of COGS have often found themselves facing penalties and back taxes.
For the Movement
Section 280E has become one of the most powerful arguments for federal cannabis reform. It illustrates the absurdity of the federal-state conflict in stark financial terms: states invite businesses to operate legally, regulate them extensively, and collect tax revenue from them — while the federal government simultaneously punishes them for existing.
The provision also raises equity concerns. Small, minority-owned cannabis businesses — many launched through social equity programs — are disproportionately harmed because they lack the capital reserves and accounting infrastructure to absorb the tax hit. The very communities that legalization was supposed to uplift are being squeezed hardest by a tax code written to punish Pablo Escobar.
What’s Next
Rescheduling and Its Tax Implications
The most significant potential relief lies in the DEA’s proposed rescheduling of cannabis from Schedule I to Schedule III, a process initiated in 2023 following an HHS recommendation. If finalized, rescheduling would effectively eliminate the 280E burden because the provision only applies to Schedule I and II substances.
However, the rescheduling timeline remains uncertain. The DEA held a public hearing in early 2025, and a final rule could take months — or longer — depending on legal challenges. Some industry groups have filed lawsuits seeking to accelerate the process.
Legislative Alternatives
Several bills in Congress have proposed 280E relief independent of rescheduling:
- The SMALL Business Tax Equity Act would exempt state-legal cannabis businesses from 280E
- The States Reform Act would deschedule cannabis entirely, removing 280E along with it
- Various bipartisan proposals have gained co-sponsors but face uncertain paths through a divided Congress
What to Watch For
- DEA final rescheduling decision — the single most impactful near-term development
- IRS enforcement posture — whether the agency adjusts audit priorities during the rescheduling process
- State-level tax reform — some states are cutting their own cannabis taxes to offset the federal burden
Key Takeaways
- Section 280E prevents cannabis businesses from deducting ordinary business expenses, resulting in effective tax rates that can exceed 70% — far beyond what any other legal industry pays
- Consumers bear the cost through higher retail prices, which also fuels the illicit market by making legal products less competitive
- Rescheduling cannabis to Schedule III would eliminate 280E, but the timeline remains uncertain and subject to legal challenges
- Small and equity-focused businesses are disproportionately harmed, undermining the social justice goals of legalization
- Until federal action occurs, cannabis operators continue navigating one of the most hostile tax environments in American business
This article is for informational and educational purposes only and does not constitute tax or legal advice. Cannabis businesses should consult qualified tax professionals regarding their specific obligations under federal and state law.
